Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT04877691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicentre, Randomised, Double-Blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy
Study identification
- NCT ID
- NCT04877691
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 367 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2021 (Actual)
- Primary completion
- Aug 22, 2025 (Actual)
- Completion
- Nov 6, 2026 (Estimated)
- Last update posted
- Jul 27, 2026
2021 – 2026
United States locations
- U.S. sites
- 33
- U.S. states
- 15
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35233 | — |
| Research Site | Paradise Valley | Arizona | 85253 | — |
| Research Site | Phoenix | Arizona | 85032 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | La Mesa | California | 91942 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Menifee | California | 92586 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Brandon | Florida | 33511 | — |
| Research Site | Clearwater | Florida | 33759 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Miami | Florida | 33180 | — |
| Research Site | Tampa | Florida | 33613 | — |
| Research Site | Tampa | Florida | 33614 | — |
| Research Site | Idaho Falls | Idaho | 83404 | — |
| Research Site | Flint | Michigan | 48504 | — |
| Research Site | Lansing | Michigan | 48911 | — |
| Research Site | Newark | New Jersey | 07103 | — |
| Research Site | Las Cruces | New Mexico | 88011 | — |
| Research Site | Brooklyn | New York | 11201 | — |
| Research Site | Manhasset | New York | 11030 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | Potsdam | New York | 13676 | — |
| Research Site | Charlotte | North Carolina | 28203 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Pittsburgh | Pennsylvania | 15224 | — |
| Research Site | Reading | Pennsylvania | 19610 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Grapevine | Texas | 76051 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04877691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04877691 live on ClinicalTrials.gov.